131.80
price up icon2.15%   2.78
pre-market  プレマーケット:  131.30   -0.50   -0.38%
loading
前日終値:
$129.02
開ける:
$128.93
24時間の取引高:
633.63K
Relative Volume:
0.86
時価総額:
$7.99B
収益:
$3.99B
当期純損益:
$463.16M
株価収益率:
18.56
EPS:
7.1
ネットキャッシュフロー:
$1.10B
1週間 パフォーマンス:
+1.85%
1か月 パフォーマンス:
+3.17%
6か月 パフォーマンス:
+6.16%
1年 パフォーマンス:
+18.30%
1日の値動き範囲:
Value
$128.49
$131.93
1週間の範囲:
Value
$125.78
$131.93
52週間の値動き範囲:
Value
$95.49
$148.06

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Name
名前
Jazz Pharmaceuticals Plc
Name
セクター
Healthcare (1147)
Name
電話
353-1-634-7800
Name
住所
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Name
職員
2,800
Name
Twitter
@jazzpharma
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
JAZZ's Discussions on Twitter

JAZZ を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
JAZZ
Jazz Pharmaceuticals Plc
131.80 7.83B 3.99B 463.16M 1.10B 7.10
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.64 101.35B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.00 58.66B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
562.27 59.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
737.56 44.01B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
340.70 36.56B 3.81B -644.79M -669.77M -6.24

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-15 開始されました Deutsche Bank Buy
2025-03-07 アップグレード UBS Neutral → Buy
2025-02-26 ダウングレード Cantor Fitzgerald Overweight → Neutral
2025-02-13 アップグレード Wells Fargo Equal Weight → Overweight
2024-12-12 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-06-05 開始されました Goldman Buy
2024-01-03 開始されました Robert W. Baird Outperform
2023-11-27 ダウングレード UBS Buy → Neutral
2023-09-29 開始されました Raymond James Mkt Perform
2023-06-12 再開されました Wells Fargo Equal Weight
2022-12-09 アップグレード Goldman Neutral → Buy
2022-06-14 開始されました UBS Buy
2022-04-06 ダウングレード Goldman Buy → Neutral
2021-11-19 再開されました Goldman Buy
2021-10-07 再開されました Jefferies Buy
2021-10-05 開始されました Citigroup Buy
2021-09-23 開始されました Needham Buy
2021-05-19 再開されました JP Morgan Overweight
2021-04-07 再開されました RBC Capital Mkts Outperform
2021-02-05 繰り返されました H.C. Wainwright Buy
2021-02-03 アップグレード Piper Sandler Neutral → Overweight
2021-01-29 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-12-16 開始されました UBS Buy
2020-11-03 繰り返されました H.C. Wainwright Buy
2020-10-09 繰り返されました H.C. Wainwright Buy
2020-09-14 ダウングレード Goldman Neutral → Sell
2020-09-14 再開されました JP Morgan Overweight
2020-08-06 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-07-28 アップグレード Wolfe Research Peer Perform → Outperform
2020-07-23 アップグレード H.C. Wainwright Neutral → Buy
2020-04-06 開始されました Jefferies Buy
2020-03-12 アップグレード Bernstein Mkt Perform → Outperform
2020-01-08 開始されました Goldman Neutral
2019-08-21 ダウングレード Piper Jaffray Overweight → Neutral
2019-06-11 開始されました Barclays Overweight
2019-03-20 開始されました SunTrust Buy
2018-12-14 開始されました Wolfe Research Peer Perform
2018-11-08 繰り返されました B. Riley FBR Buy
2018-08-08 繰り返されました Stifel Buy
2018-07-11 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-03-23 繰り返されました H.C. Wainwright Neutral
2018-03-19 アップグレード Morgan Stanley Equal-Weight → Overweight
すべてを表示

Jazz Pharmaceuticals Plc (JAZZ) 最新ニュース

pulisher
03:38 AM

Will Jazz Pharmaceuticals plc stock rally after Fed decisionsRisk Management & Consistent Profit Alerts - newser.com

03:38 AM
pulisher
03:27 AM

Park Avenue Securities LLC Takes Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

03:27 AM
pulisher
Sep 30, 2025

Will Jazz Pharmaceuticals plc (J7Z) stock remain on Wall Street radarMarket Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Will Jazz Pharmaceuticals plc stock keep outperforming rivalsBuy Signal & Fast Gain Swing Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

What MACD and RSI say about Jazz Pharmaceuticals plcEarnings Performance Report & Weekly Sector Rotation Insights - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Will Jazz Pharmaceuticals plc (J7Z) stock announce special dividendOptions Play & Real-Time Volume Trigger Notifications - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Jazz Pharmaceuticals (JAZZ) Stock Analysis: 47% Potential Upside Catches Investor Attention - DirectorsTalk Interviews

Sep 29, 2025
pulisher
Sep 29, 2025

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 47% Upside Potential Beckons Investors - DirectorsTalk Interviews

Sep 29, 2025
pulisher
Sep 29, 2025

State of Alaska Department of Revenue Boosts Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

Why Jazz Pharmaceuticals plc (J7Z) stock could be top winner2025 Big Picture & AI Forecasted Stock Moves - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

What analysts say about Jazz Pharmaceuticals plc stockFederal Reserve Announcements & Small Investment Trading Tips - earlytimes.in

Sep 29, 2025
pulisher
Sep 28, 2025

Jazz Pharmaceuticals plc J7Z Stock Analysis and ForecastTechnical Resistance Breaks & Low Cost Wealth Plans - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

What analysts say about Jazz Pharmaceuticals plc J7Z stockRSI Overbought/Oversold & Free Daily Stock Hotspot Analysis - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

Are Jazz Pharmaceuticals Shares Set for a Rebound After Recent Drug Approval in 2025? - simplywall.st

Sep 27, 2025
pulisher
Sep 27, 2025

Is Jazz Pharmaceuticals plc a candidate for recovery playOptions Play & Weekly Chart Analysis and Guides - newser.com

Sep 27, 2025
pulisher
Sep 27, 2025

Piper Sandler Reaffirms Jazz Pharmaceuticals (JAZZ) Price Target Ahead of Trial Data - MSN

Sep 27, 2025
pulisher
Sep 26, 2025

What drives Jazz Pharmaceuticals plc stock priceDividend Stock Watch & Exceptional Capital Investment - Early Times

Sep 26, 2025
pulisher
Sep 26, 2025

Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com

Sep 26, 2025
pulisher
Sep 26, 2025

EClinical Solutions Explores Data Intelligence in Modern Clinical Trials at ENGAGE 2025 - MarketScreener

Sep 26, 2025
pulisher
Sep 25, 2025

JAZZ: Morgan Stanley Raises Price Target to $167, Maintains Over - GuruFocus

Sep 25, 2025
pulisher
Sep 25, 2025

Affinity Wealth Management LLC Purchases New Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Sep 25, 2025
pulisher
Sep 25, 2025

United States Myelodysplastic Syndrome Treatment Market - openPR.com

Sep 25, 2025
pulisher
Sep 25, 2025

Amneal wins FDA nod for generic targeting Jazz Pharma’s Xyrem - MSN

Sep 25, 2025
pulisher
Sep 24, 2025

Jazz Pharmaceuticals Secures Dismissal of Patent Fraud Lawsuit - Bloomberg Law News

Sep 24, 2025
pulisher
Sep 24, 2025

Jazz Pharmaceuticals Announces Promising Xywav Data: Why I Assign A BUY Rating - Seeking Alpha

Sep 24, 2025
pulisher
Sep 24, 2025

Here's Why JAZZ Stock Is an Unconventional Cannabis Investment - The Globe and Mail

Sep 24, 2025
pulisher
Sep 24, 2025

Morgan Stanley Issues Positive Forecast for Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Price - MarketBeat

Sep 24, 2025
pulisher
Sep 24, 2025

Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Perpetual Ltd - MarketBeat

Sep 24, 2025
pulisher
Sep 24, 2025

Jazz Pharmaceuticals PLC $JAZZ Shares Bought by CX Institutional - MarketBeat

Sep 24, 2025
pulisher
Sep 23, 2025

Jazz Pharmaceuticals plc (JAZZ) Advances Rare Cancer Portfolio with First CNS Glioma Therapy Approval - Yahoo Finance

Sep 23, 2025
pulisher
Sep 23, 2025

Jazz Pharmaceuticals stock price target raised to $167 from $163 at Morgan Stanley - Investing.com UK

Sep 23, 2025
pulisher
Sep 23, 2025

Jazz Pharmaceuticals (JAZZ): Assessing Valuation Following Fresh Xywav Clinical Data at Leading Medical Conferences - simplywall.st

Sep 23, 2025
pulisher
Sep 23, 2025

Wedmont Private Capital Decreases Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Sep 23, 2025
pulisher
Sep 22, 2025

Jazz Pharmaceuticals stock hits 52-week high of $134.24 - MSN

Sep 22, 2025
pulisher
Sep 22, 2025

Swedbank AB Lowers Stock Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Jazz pharma presents new data on narcolepsy and hypersomnia treatment - Investing.com

Sep 22, 2025
pulisher
Sep 22, 2025

Jazz Pharmaceuticals presents Xywav data at medical conferences - StreetInsider

Sep 22, 2025
pulisher
Sep 22, 2025

Jazz Pharmaceuticals Showcases Phase 4 Data Demonstrating Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Effects and Real-World Evidence at World Sleep and Psych Congresses - PR Newswire

Sep 22, 2025
pulisher
Sep 22, 2025

United States Narcolepsy Therapeutics Market Trends & Growth - openPR.com

Sep 22, 2025
pulisher
Sep 22, 2025

Voya Investment Management LLC Acquires 22,628 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Sep 22, 2025
pulisher
Sep 21, 2025

How NCCN Endorsement of Modeyso May Shape Jazz Pharmaceuticals' (JAZZ) Rare Oncology Expansion - simplywall.st

Sep 21, 2025
pulisher
Sep 21, 2025

Jazz Pharmaceuticals PLC $JAZZ Shares Sold by MassMutual Private Wealth & Trust FSB - MarketBeat

Sep 21, 2025
pulisher
Sep 21, 2025

Strs Ohio Purchases Shares of 16,445 Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

Jazz Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo

Sep 20, 2025
pulisher
Sep 20, 2025

Lingohr Asset Management GmbH Sells 37,288 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Sep 20, 2025

Jazz Pharmaceuticals Plc (JAZZ) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
大文字化:     |  ボリューム (24 時間):